Conference
Fondaparinux is associated with substantially less major bleeding and vascular access site complications compared with enoxaparin in patients with acute coronary syndrome undergoing percutaneous coronary intervention: Insights from the OASIS 5 trial
Authors
Mehta SR; Bassand JP; Granger CB; Widimsky P; Steg PG; Rupprecht HJ; Faxon DP; Afzal R; Chrolavicius S; Meeks B
Volume
47
Pagination
pp. 205A-205A
Publisher
ELSEVIER SCIENCE INC
Publication Date
February 21, 2006
Name of conference
55th Annual Scientific Session of the American-College-of-Cardiology
Conference place
Atlanta, GA
Conference start date
March 11, 2006
Conference end date
March 14, 2006
Conference proceedings
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
Issue
4
ISSN
0735-1097